Protalix BioTherapeutics (PLX) Reports FY Loss of $0.08
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.22 -5.93%
Revenue Growth %: -49.8%
Financial Fact:
RESEARCH AND DEVELOPMENT EXPENSES: -6.35M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Revenue Growth %: -49.8%
Financial Fact:
RESEARCH AND DEVELOPMENT EXPENSES: -6.35M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported FY EPS of ($0.08). Revenue for the period came in at $52.74 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
